近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Feng Y, He F, Yan S, Huang H, Huang Q, Deng T, Wu H, Gao B, Liu J（*）. The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer. J Cancer. 2017 Feb 10;8(3):443-454
2.Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J（*）. Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer：A Systematic Review and Meta-analysis. International Journal of Gynecological Cancer.2017 Jan;27(1):77-84.
3.Feng Y, Cao T, Wang Y, Huang H, Xie Y, Liu J（*）. Neoadjuvant chemotherapy followed by conization to spare fertility in cases of locally advanced cervical cancer：A case report and review of the literature. Mol Clin Oncol. 2016 Oct;5(4):411-416
4.Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J（*）. Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer：A Systematic Review and Meta-analysis. Int J Gynecol Cancer. 2017 Jan;27(1):77-84
5.Tu H, Xiong Y, Huang H, Huang Y, Wan T, Deng T, Liu J（*）. Individualized Treatment of Patients With Early-Stage Epithelial Ovarian Cancer After Incomplete Initial Surgery. Int J Gynecol Cancer. 2016 Jan;26(1):73-81
6.Chunyan Lan, Xin Huang, Qidan Huang, Yin Wang, Haifeng Gu, Yong Li, Jihong Liu（*）. "Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?" Int J Gynecol Cancer 2015;25: 1445-1452
7.Chunyan Lan, Andreas Heindl, Xin Huang, Shaoyan Xi, Susana Banerjee, Jihong Liu（*）, and Yinyin Yuan. Quantitative histology analysis of the ovarian tumour microenvironment. Sci Rep. 2015; 5: 16317.
8.Tiefeng Cao, Yanling Feng, Qidan Huang, Ting Wan, and Jihong Liu（*）. Prognostic and Safety Roles in Laparoscopic Versus Abdominal Radical Hysterectomy in Cervical Cancer:A Meta-analysis. J Laparoendosc Adv Surg Tech A.2015 Dec;25(12):990-8
9.Yong-Wen Huang,* Yun Zhou,* Chun-Yan Lan,Yin Wang,Yan-Ling Feng, Rong-Zhen Luo, and Ji-Hong Liu（*）. Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits. Drug Des Devel Ther. 2015; 9: 5949–5956.
10.Yanling Feng, Fan He, Huini Wu, He Huang, Lan Zhang, Xian Han, Jihong Liu（*）GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer. Journal of Cancer 2015; 6(9): 893-900.
11.Deng T, Feng Y, Zheng J, Huang Q, Liu J（*）. Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery. J Gynecol Oncol. 2015;26:111-7.
12.Lan C, Huang X, Huang Y, Xi S, Huang H, Feng Y, Liu J（*）.The outcome and efficacy of adjuvant chemotherapy alone in patients with stage IIIA endometrial carcinoma with solitary adnexal involvement: A retrospective single-institution study..Gynecol Oncol. 2014, 135(3):446–450
13.Lan Zhang, He HuangLongjuan Zhang, Teng Hou, Shu Wu, Qidan Huang, Libing Song（*）,Jihong Liu（*）.URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer. BMC Cancer. 2014, 14(1):1-11
14.顾海风, 刘继红. 子宫颈癌前哨淋巴结的研究进展. 中华妇产科杂志，2014，10，49(10):798-800.
15.熊樱, 刘继红. P53凋亡刺激蛋白抑制因子在人类恶性肿瘤的研究进展. 妇产与遗传2014,4(1):41-4.
16.孙 菲, 李艳芳, 刘继红, 熊 樱. 208例低危型宫颈癌患者的辅助治疗及预后相关因素分析. J South Med Univ, 2014, 34(3): 401-405.
17.Huang H, Li YJ, Lan CY, Huang QD, Feng YL, Huang YW, Liu JH（*）. Clinical significance of ascites in epithelial ovarian cancer. Neoplasma. 2013;60(5):546-52.
18.Shi Y, Li L, Hu Z, Li S, Wang S, Liu J（*）, etc. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet. 2013 Aug;45(8):918-22.（共同第一作者）
19.Lan C, Huang X, Cao X, Huang H, Feng Y, Huang Y, Liu J（*）. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience. Expert Opin Pharmacother. 2013;14(5):535-42.
20.Huang Q, Huang H, Wan T, Deng T, Liu J（*）. Clinical outcome of 31 patients with primary malignant melanoma of the vagina. J Gynecol Oncol. 2013 ;24(4):330-5.
21.Huang YW, Guan MF, Liu JH, Lan CY, Wan T, Huang X. Large animal model for retroperitoneal lymphatic and lung metastasis.Mol Med Rep. 2013;8(6):1617-22.
22.Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J（*）. Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer. Technol Cancer Res Treat. 2013;12(3):259-67.
23.Lan C, Huang X, Lin S, Huang H, Cai Q, Lu J, Liu J（*）.High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res. 2013 May;352(2):351-9.
24.Xiong Y, Liu JH, Zheng M, Cao LP, Liang LZ. Use of preoperative clinicopathologic characteristics to identify patients with low-risk cervical cancer suitable for Piver class II radical hysterectomy. INT J GYNECOL OBSTET. 2013 Apr 1. pii: S0020-7292(13)00138-0.
25.Li Z, Yu CP, Zhong Y, Liu TJ, Huang QD, Zhao XH, Huang H, Tu H, Jiang S, Zhang Y, Liu JH（*）& Song LB（*）. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol. 2012 Mar;23(3):638-46. Epub 2011 Jun 23.
26.Huang YW, Zeng Z, Li S, Liu JH（*）. Differential routes of carboplatin administration influence lymphocyte apoptosis in retroperitoneal lymph nodes. Tumour Biol. 2012 Dec;33(6):2053-9.
27.Lan C, Huang X, Lin S, Cai M, Liu J（*）. Endometrial Stromal Sarcoma Arising from Endometriosis: A Clinicopathological Study and Literature Review. Gynecol Obstet Invest 2012;74:288-297.
28.Huang H, Li Y, Liu J（*）, Zheng M, Feng Y, Hu K, Huang Y, Huang Q. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers. PLoS One. 2012;7(12):e51256. doi: 10.1371/journal.pone.0051256. Epub 2012 Dec 10.
29.Ying Xiong, Li-Ping Cao , Hui-Lan Rao , Mu-Yan Cai ,Li-Zhi Liang , Ji-Hong Liu（*）. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer. Cell Tissue Res (2012) 348:515–522
30.Xiong Y, Liang LZ, Cao LP, Min Z, Liu JH（*）. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical. Gynecol Oncol. 2011 Oct;123(1):99-104. Epub 2011 Jul 8.
31.Huang H, Liu J（*）, Li Y, Wan T, Feng Y, Li Z, Huang Q.Metastasis to deep obturator and para-aortic lymph nodes in 649 patients withcervical carcinoma. Eur J Surg Oncol. 2011 Nov;37(11):978-83. Epub 2011 Sep 9.
32.Liu JH, B Rose，Huang X, Liao GW, J Carter, Wu XJ, C Thompson , Comparative analysis of characteristics of women with cervical cancer in high- versus low- incidence regions Gynecologic Oncology 2004,3(94):803-810
33.Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of eJF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecology Oncology，2008.
34.Li W, C Thompson, Y E Cossart, C J O’Brien, Liu JH, R A Scolyer, J Carter, C Dalrymple, B Rose. The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer Modern Pathology 2004, 17:1031-1037
35.黄绮丹，黄鹤，刘继红. 64 例 Ⅳ期上皮性卵巢癌的临床分析. 热带医学杂志，2013,1,13(1):79-82
36.涂画，黄鹤，黄绮丹，李政，冯艳玲，刘继红（*）.卵巢上皮性癌患者术后单纯淋巴结区域复发的治疗及预后分析. 中华妇产科杂志，2012，12，47(12):928-33
37.李玉洁,黄鹤,刘继红（*）,蓝春燕.三阶梯技术在436例宫颈病变中的应用价值探讨. 实用妇产科杂志. 2012.28（1）：53-56.
38.陈鹏，曾峥，黄鹤，涂画，刘继红（*）. 吲哚胺-2,3-双加氧酶在卵巢浆液性腺癌中的表达及临床意义. 中国实用妇科与产科杂志. 2012.28（增刊）：20-22
39.李明伟, 刘继红（*）.TrkB及其配体BDNF在卵巢上皮癌中的表达及其临床意义. 中国妇产科临床杂志 2012,13(2):122-125
京公网安备 11010802027423号